September 12, 2007 -- A Wall Street Journal article considered the future of two China drug companies that have listed recently on US exchanges, Simcere Pharma and Tongjitang China Medicine. Regulatory reform in China has put some pressure on the prices of both stocks. Now, they seem to be bargains. More details...
